Imipramine Hydrochloride
Imipramine Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Imipramine Hydrochloride; Generic name: IMIPRAMINE HYDROCHLORIDE; Manufacturer: REMEDYREPACK INC..
| Brand name | Imipramine Hydrochloride |
|---|---|
| Generic name | IMIPRAMINE HYDROCHLORIDE |
| Manufacturer | REMEDYREPACK INC. |
| Used for | INDICATIONS AND USAGE Depression -For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. One to three weeks of treatment may be needed before optimal therapeutic effects are evident. Childhood Enuresis -May be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. In patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. The effectiveness of treatment may decrease with continued drug administration. |
| Dosage | DOSAGE AND ADMINISTRATION Depression Lower dosages are recommended for elderly patients and adolescents. Lower dosages are also recommended for outpatients as compared to hospitalized patients who will be under close supervision. Dosage should be initiated at a low level and increased gradually, noting carefully the clinical response and any evidence of intolerance. Following remission, maintenance medication may be required for a longer period of time, at the lowest dose that will maintain remi |
| Warnings | WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are t |
| Active ingredient(s) | IMIPRAMINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02c19a0a-3d9d-4881-ad14-1687aafd87b5 |